ADVERSE EVENT REPORTING OF MARKETED BIOSIMILAR AND BIOLOGICAL MONOCLONAL ANTIBODY CANCER TREATMENTS IN THE UNITED STATES

被引：0
|
作者：
Xue, X. [1 ]
Truong, B. [2 ]
Qian, J. [3 ]
机构：
[1] Auburn Univ, Harrison Sch Pharm, Auburn, AL USA
[2] Auburn Univ, Harrison Coll Pharm, Auburn, AL USA
[3] Auburn Univ, Harrison Coll Pharm, Auburn, AL USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD30
引用
收藏
页码：S365 / S366
页数：2
相关论文
共 50 条
  • [1] Adverse event reporting of marketed biosimilar and biological monoclonal antibody cancer treatments in the United States
    Xue, Xiangzhong
    Truong, Bang
    Qian, Jingjing
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (08) : 841 - 849
  • [2] ADVERSE EVENT REPORTING OF MARKETING BIOSIMILAR AND BIOLOGICAL MONOCLONAL ANTIBODY CANCER TREATMENTS
    Xue, X. Xiangzhong
    Qian, J.
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2023, 19 (03): : 564 - 564
  • [3] Safety of marketed biosimilar monoclonal antibody cancer treatments in the US: a disproportionality analysis using the food and drug administration adverse event reporting system (FAERS) database
    Xue, Xiangzhong
    Qian, Jingjing
    [J]. EXPERT OPINION ON DRUG SAFETY, 2024,
  • [4] The state of dietary supplement adverse event reporting in the United States
    Gardiner, Paula
    Sarma, Dandapantula N.
    Dog, Tieraona Low
    Barrett, Marilyn L.
    Chavez, Mary L.
    Ko, Richard
    Mahady, Gail B.
    Marles, Robin J.
    Pellicore, Linda S.
    Giancaspro, Gabriel I.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (10) : 962 - 970
  • [5] ADVERSE DRUG EVENT REPORTING - IMPROVING THE LOW UNITED-STATES REPORTING RATES
    EDLAVITCH, SA
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (07) : 1499 - 1503
  • [6] Does the spontaneous adverse event reporting pattern for a monoclonal antibody exhibit the Weber effect?
    Oladipo, A.
    Mendelsohn, A. B.
    Yonren, S.
    [J]. DRUG SAFETY, 2006, 29 (10) : 938 - 938
  • [7] Antiviral influenza treatments and hemorrhage-related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database
    Sarker, Jyotirmoy
    Carkovic, Emir
    Ptaszek, Karolina
    Lee, Todd A.
    [J]. PHARMACOTHERAPY, 2024, 44 (05): : 383 - 393
  • [8] Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
    Toki T.
    Ono S.
    [J]. Drugs - Real World Outcomes, 2018, 5 (2) : 117 - 128
  • [9] Trends in Human Papillomavirus Vaccine Safety Concerns and Adverse Event Reporting in the United States
    Sonawane, Kalyani
    Lin, Yueh-Yun
    Damgacioglu, Haluk
    Zhu, Yenan
    Fernandez, Maria E.
    Montealegre, Jane R.
    Cazaban, Cecilia Ganduglia
    Li, Ruosha
    Lairson, David R.
    Lin, Ying
    Giuliano, Anna R.
    Deshmukh, Ashish A.
    [J]. JAMA NETWORK OPEN, 2021, 4 (09)
  • [10] Effects of consumer adverse event reporting for a monoclonal antibody indicated in a paediatric population on risk communication tools
    Oladipo, A.
    Mendelsohn, A. B.
    Roncal, J.
    Yonren, S.
    [J]. DRUG SAFETY, 2006, 29 (10) : 945 - 945
12345